PortalPublikationenDelay in diagnosis and referral patterns of 646 patients wit...

Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer

Standard

Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer : a report from a single institution in Hamburg, Germany. / Friedrich, Reinhard E.

in: ANTICANCER RES, Jahrgang 30, Nr. 5, 01.05.2010, S. 1833-6.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Friedrich, RE 2010, 'Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer: a report from a single institution in Hamburg, Germany', ANTICANCER RES, Jg. 30, Nr. 5, S. 1833-6.

APA

Friedrich, R. E. (2010). Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer: a report from a single institution in Hamburg, Germany. ANTICANCER RES, 30(5), 1833-6.

Vancouver

Friedrich RE. Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer: a report from a single institution in Hamburg, Germany. ANTICANCER RES. 2010 Mai 1;30(5):1833-6.

Bibtex

@article{8d2490a4b1f9424ca8f31dbf44160c83,
title = "Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer: a report from a single institution in Hamburg, Germany",
abstract = "UNLABELLED: Improvement in therapy for malignant diseases in the oral and maxillofacial (OMF) region rests mainly upon diagnosis at an early stage of the disease. This study performed an analysis of the delays between symptom onset and time taken for patients to seek medical advice and then their subsequent specialist referral to the Department of OMF Surgery at Eppendorf University Hospital.PATIENTS AND METHODS: The files of 646 patients (males: 451, females: 195) with malignancies of the OMF region who were treated during an interval of 19 years were analysed retrospectively.RESULTS: Localized swelling, pain and alterations of the mucosa were the predominant first signs and symptoms of disease. Stage grouping according to the TNM system (UICC, 1992) revealed advanced stages in the majority of cases (IV: 30%, III: 15%). The majority of patients were referred by residents in OMF surgery (31.7%) and dentists (28.8%) and were hospitalized within 4 months after notification of the first symptoms (66.9%).CONCLUSION: Both outreach work of public health institutions and continuous education during studies in both medicine and dentistry, and in further education play a key role in reducing diagnostic delay in OMF cancer.",
keywords = "Adult, Aged, Female, Germany, Head and Neck Neoplasms, Humans, Male, Middle Aged, Mouth Neoplasms, Neoplasm Staging, Referral and Consultation, Retrospective Studies, Risk Factors, Surgery, Oral, Time Factors",
author = "Friedrich, {Reinhard E}",
year = "2010",
month = may,
day = "1",
language = "English",
volume = "30",
pages = "1833--6",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

RIS

TY - JOUR

T1 - Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer

T2 - a report from a single institution in Hamburg, Germany

AU - Friedrich, Reinhard E

PY - 2010/5/1

Y1 - 2010/5/1

N2 - UNLABELLED: Improvement in therapy for malignant diseases in the oral and maxillofacial (OMF) region rests mainly upon diagnosis at an early stage of the disease. This study performed an analysis of the delays between symptom onset and time taken for patients to seek medical advice and then their subsequent specialist referral to the Department of OMF Surgery at Eppendorf University Hospital.PATIENTS AND METHODS: The files of 646 patients (males: 451, females: 195) with malignancies of the OMF region who were treated during an interval of 19 years were analysed retrospectively.RESULTS: Localized swelling, pain and alterations of the mucosa were the predominant first signs and symptoms of disease. Stage grouping according to the TNM system (UICC, 1992) revealed advanced stages in the majority of cases (IV: 30%, III: 15%). The majority of patients were referred by residents in OMF surgery (31.7%) and dentists (28.8%) and were hospitalized within 4 months after notification of the first symptoms (66.9%).CONCLUSION: Both outreach work of public health institutions and continuous education during studies in both medicine and dentistry, and in further education play a key role in reducing diagnostic delay in OMF cancer.

AB - UNLABELLED: Improvement in therapy for malignant diseases in the oral and maxillofacial (OMF) region rests mainly upon diagnosis at an early stage of the disease. This study performed an analysis of the delays between symptom onset and time taken for patients to seek medical advice and then their subsequent specialist referral to the Department of OMF Surgery at Eppendorf University Hospital.PATIENTS AND METHODS: The files of 646 patients (males: 451, females: 195) with malignancies of the OMF region who were treated during an interval of 19 years were analysed retrospectively.RESULTS: Localized swelling, pain and alterations of the mucosa were the predominant first signs and symptoms of disease. Stage grouping according to the TNM system (UICC, 1992) revealed advanced stages in the majority of cases (IV: 30%, III: 15%). The majority of patients were referred by residents in OMF surgery (31.7%) and dentists (28.8%) and were hospitalized within 4 months after notification of the first symptoms (66.9%).CONCLUSION: Both outreach work of public health institutions and continuous education during studies in both medicine and dentistry, and in further education play a key role in reducing diagnostic delay in OMF cancer.

KW - Adult

KW - Aged

KW - Female

KW - Germany

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Mouth Neoplasms

KW - Neoplasm Staging

KW - Referral and Consultation

KW - Retrospective Studies

KW - Risk Factors

KW - Surgery, Oral

KW - Time Factors

M3 - SCORING: Journal article

C2 - 20592388

VL - 30

SP - 1833

EP - 1836

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 5

ER -